camptothecin has been researched along with Wilms Tumor in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergeron, C; Brok, J; Catania, S; Graf, N; Hol, JA; Howell, L; Kager, L; Mavinkurve-Groothuis, AMC; Pritchard-Jones, K; Spreafico, F; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, A | 1 |
Malogolowkin, MH; Mascarenhas, L; Venkatramani, R | 1 |
Hanada, R; Kawa, K; Manabe, A; Matsunaga, T; Mimaya, J; Mugishima, H; Shimada, A; Shitara, T; Sugimoto, T; Tsuchida, Y; Tsurusawa, M | 1 |
2 trial(s) available for camptothecin and Wilms Tumor
Article | Year |
---|---|
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.
Topics: Adolescent; Camptothecin; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Irinotecan; Kidney Neoplasms; Male; Risk Factors; Wilms Tumor | 2018 |
Irinotecan for children with relapsed solid tumors.
Topics: Camptothecin; Child; Child, Preschool; Female; Humans; Infant; Irinotecan; Male; Neoplasms; Neuroblastoma; Recurrence; Remission Induction; Rhabdomyosarcoma; Tumor Burden; Wilms Tumor | 2006 |
1 other study(ies) available for camptothecin and Wilms Tumor
Article | Year |
---|---|
Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Child; Dacarbazine; Female; Humans; Irinotecan; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Temozolomide; Vincristine; Wilms Tumor | 2014 |